These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18278175)

  • 1. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
    Barberis L; Hirsch E
    Thromb Haemost; 2008 Feb; 99(2):279-85. PubMed ID: 18278175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing.
    Hirsch E; Lembo G; Montrucchio G; Rommel C; Costa C; Barberis L
    Thromb Haemost; 2006 Jan; 95(1):29-35. PubMed ID: 16543958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac regulation by phosphoinositide 3-kinases and PTEN.
    Oudit GY; Penninger JM
    Cardiovasc Res; 2009 May; 82(2):250-60. PubMed ID: 19147653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3Kgamma is a key regulator of inflammatory responses and cardiovascular homeostasis.
    Hawkins PT; Stephens LR
    Science; 2007 Oct; 318(5847):64-6. PubMed ID: 17916723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class IA phosphoinositide 3-kinase isoforms and human tumorigenesis: implications for cancer drug discovery and development.
    Wee S; Lengauer C; Wiederschain D
    Curr Opin Oncol; 2008 Jan; 20(1):77-82. PubMed ID: 18043260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte transmigration is modulated by chemokine-mediated PI3Kgamma-dependent phosphorylation of vimentin.
    Barberis L; Pasquali C; Bertschy-Meier D; Cuccurullo A; Costa C; Ambrogio C; Vilbois F; Chiarle R; Wymann M; Altruda F; Rommel C; Hirsch E
    Eur J Immunol; 2009 Apr; 39(4):1136-46. PubMed ID: 19291697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment.
    Ferrandi C; Ardissone V; Ferro P; Rückle T; Zaratin P; Ammannati E; Hauben E; Rommel C; Cirillo R
    J Pharmacol Exp Ther; 2007 Sep; 322(3):923-30. PubMed ID: 17526805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice.
    Takeda M; Ito W; Tanabe M; Ueki S; Kato H; Kihara J; Tanigai T; Chiba T; Yamaguchi K; Kayaba H; Imai Y; Okuyama K; Ohno I; Sasaki T; Chihara J
    J Allergy Clin Immunol; 2009 Apr; 123(4):805-12. PubMed ID: 19232703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of class IA PI3Ks.
    Wu H; Yan Y; Backer JM
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):242-4. PubMed ID: 17371249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?
    Rommel C; Camps M; Ji H
    Nat Rev Immunol; 2007 Mar; 7(3):191-201. PubMed ID: 17290298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma.
    Pomel V; Klicic J; Covini D; Church DD; Shaw JP; Roulin K; Burgat-Charvillon F; Valognes D; Camps M; Chabert C; Gillieron C; Françon B; Perrin D; Leroy D; Gretener D; Nichols A; Vitte PA; Carboni S; Rommel C; Schwarz MK; Rückle T
    J Med Chem; 2006 Jun; 49(13):3857-71. PubMed ID: 16789742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taming the PI3K team to hold inflammation and cancer at bay.
    Hirsch E; Ciraolo E; Ghigo A; Costa C
    Pharmacol Ther; 2008 May; 118(2):192-205. PubMed ID: 18420279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3Kgamma inhibition: towards an 'aspirin of the 21st century'?
    Rückle T; Schwarz MK; Rommel C
    Nat Rev Drug Discov; 2006 Nov; 5(11):903-18. PubMed ID: 17080027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase gamma.
    Costa C; Barberis L; Ambrogio C; Manazza AD; Patrucco E; Azzolino O; Neilsen PO; Ciraolo E; Altruda F; Prestwich GD; Chiarle R; Wymann M; Ridley A; Hirsch E
    Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14354-9. PubMed ID: 17720808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
    Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
    Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiological roles of PI3Ks and therapeutic potential of selective inhibitors in allergic inflammation.
    Takeda M; Ito W; Tanabe M; Ueki S; Kihara J; Kato H; Tanigai T; Kayaba H; Sasaki T; Chihara J
    Int Arch Allergy Immunol; 2010; 152 Suppl 1():90-5. PubMed ID: 20523070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3 kinases in cancer: from oncogene artifact to leading cancer target.
    Zhao JJ; Roberts TM
    Sci STKE; 2006 Dec; 2006(365):pe52. PubMed ID: 17164467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the macromolecular complex responsible for PI3Kgamma-dependent regulation of cAMP levels.
    Perino A; Ghigo A; Damilano F; Hirsch E
    Biochem Soc Trans; 2006 Aug; 34(Pt 4):502-3. PubMed ID: 16856844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoinositide 3-kinase signalling in the vascular system.
    Morello F; Perino A; Hirsch E
    Cardiovasc Res; 2009 May; 82(2):261-71. PubMed ID: 19038971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K class IB pathway.
    Andrews S; Stephens LR; Hawkins PT
    Sci STKE; 2007 Oct; 2007(407):cm2. PubMed ID: 17925573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.